LINC01410 and central nervous system cancer: In gliomas, Analysis using the GEPIA2 database revealed that LINC01410 expression was significantly higher in tumor tissues compared with normal tissues, and it was also highly expressed in multiple glioma cell lines (SHG44, T98G, LN229, A172) (29).Luciferase reporter assays confirmed the interaction between LINC01410 and miR-506-3p, and silencing LINC01410 markedly reduced the activity of the Notch signaling pathway.